Federated Hermes Portfolio holdings
AUM
$53.1B
1-Year Return
30.23%
This Quarter Return
+14.33%
1 Year Return
+30.23%
3 Year Return
+93.51%
5 Year Return
+187.87%
10 Year Return
+487.63%
AUM
$40.3B
AUM Growth
+$2.76B
(+7.3%)
Cap. Flow
-$1.61B
Cap. Flow
% of AUM
-3.99%
Top 10 Holdings %
Top 10 Hldgs %
13.58%
Holding
2,266
New
182
Increased
650
Reduced
1,111
Closed
232
Top Buys
| 1 |
GoDaddy
GDDY
|
$98.5M |
| 2 |
Morgan Stanley
MS
|
$78.9M |
| 3 |
AbbVie
ABBV
|
$67.8M |
| 4 |
Kenvue
KVUE
|
$65.1M |
| 5 |
GE Aerospace
GE
|
$61.2M |
Top Sells
| 1 |
Amgen
AMGN
|
$219M |
| 2 |
Williams Companies
WMB
|
$149M |
| 3 |
Verizon
VZ
|
$136M |
| 4 |
SPLK
Splunk Inc
SPLK
|
$123M |
| 5 |
PNC Financial Services
PNC
|
$97.4M |
Sector Composition
| 1 | Healthcare | 18.2% |
| 2 | Technology | 16.32% |
| 3 | Financials | 12.58% |
| 4 | Industrials | 9.74% |
| 5 | Consumer Discretionary | 9.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
326
Braze
BRZE
$3.5B
| $26.8M | 0.07% |
503,994
+239,742
| +91% | +$12.7M |
|
327
Qorvo
QRVO
$8.61B
| $26.7M | 0.07% |
237,251
+21,093
| +10% | +$2.38M |
|
328
Jackson Financial
JXN
$6.65B
| $26.7M | 0.07% |
521,266
+192,995
| +59% | +$9.88M |
|
|
DCBO
329
Docebo
DCBO
$896M
| $26.6M | 0.07% |
549,449
| – | – |
|
330
A.O. Smith
AOS
$10.3B
| $26.3M | 0.07% |
318,893
+1,569
| +0.5% | +$129K |
|
331
Alnylam Pharmaceuticals
ALNY
$59.4B
| $26.3M | 0.07% |
+137,141
| New | +$26.3M |
|
332
General Motors
GM
$55.5B
| $26.2M | 0.07% |
730,029
+78,938
| +12% | +$2.84M |
|
333
Citigroup
C
$176B
| $26.2M | 0.06% |
508,471
-109,620
| -18% | -$5.64M |
|
334
Biogen
BIIB
$20.6B
| $25.9M | 0.06% |
100,148
-4,320
| -4% | -$1.12M |
|
335
Bio-Rad Laboratories Class A
BIO
$8B
| $25.7M | 0.06% |
79,490
+17,762
| +29% | +$5.74M |
|
336
Power Integrations
POWI
$2.52B
| $25.5M | 0.06% |
311,010
+2,985
| +1% | +$245K |
|
337
SBA Communications
SBAC
$21.2B
| $25.5M | 0.06% |
100,600
-27,016
| -21% | -$6.85M |
|
338
Intercontinental Exchange
ICE
$99.8B
| $25.3M | 0.06% |
196,745
-927
| -0.5% | -$119K |
|
339
General Mills
GIS
$27B
| $25M | 0.06% |
384,416
-38,764
| -9% | -$2.53M |
|
340
Nike
NKE
$109B
| $24.9M | 0.06% |
228,973
-98,115
| -30% | -$10.7M |
|
341
Vaxcyte
PCVX
$4.29B
| $24.8M | 0.06% |
394,192
-1,615
| -0.4% | -$101K |
|
342
Novo Nordisk
NVO
$245B
| $24.7M | 0.06% |
238,828
-5,988
| -2% | -$619K |
|
343
Guardant Health
GH
$7.5B
| $24.5M | 0.06% |
907,200
-202,300
| -18% | -$5.47M |
|
344
MYR Group
MYRG
$2.79B
| $24.5M | 0.06% |
169,319
-1,359
| -0.8% | -$197K |
|
345
TD Synnex
SNX
$12.3B
| $24.4M | 0.06% |
227,045
-127,573
| -36% | -$13.7M |
|
346
Parker-Hannifin
PH
$96.1B
| $24.3M | 0.06% |
52,740
+12,398
| +31% | +$5.71M |
|
347
CAVA Group
CAVA
$7.73B
| $24.3M | 0.06% |
565,054
+115,054
| +26% | +$4.95M |
|
348
IBM
IBM
$232B
| $24.1M | 0.06% |
147,493
-415,039
| -74% | -$67.9M |
|
349
HCA Healthcare
HCA
$98.5B
| $23.9M | 0.06% |
88,472
+1,153
| +1% | +$312K |
|
350
Mastercard
MA
$528B
| $23.8M | 0.06% |
55,823
-43,372
| -44% | -$18.5M |
|